Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers Meeting Abstract
| Authors: | Ho, A. L.; Foster, N. R.; Zoroufy, A. J.; Worden, F. P.; Andress, K.; Price, R.; Adkins, D.; Bowles, D. W.; Kang, H.; Burtness, B.; Sherman, E. J.; Morton, R. F.; Katabi, N.; Munster, P. N.; Schwartz, G. K. |
| Abstract Title: | Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 346s |
| Language: | English |
| ACCESSION: | WOS:000487345805604 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.6020 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6020 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
